|
|||||
|
|

Dental products company Envista Holdings (NYSE:NVST) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.7% year on year to $682.1 million. Its non-GAAP profit of $0.26 per share was 13.5% above analysts’ consensus estimates.
Is now the time to buy NVST? Find out in our full research report (it’s free).
Envista’s Q2 results received a strong positive response from the market, reflecting solid execution across its dental portfolio. Management pointed to broad-based revenue growth in both Equipment & Consumables and Specialty Products, with notable strength in orthodontics—particularly Brackets & Wires and Spark Clear Aligners. CEO Paul Keel explained that “core growth came in at 5.6%, aided by some customer buying in advance of expected price and tariff increases,” while margin gains were also attributed to ongoing cost reduction efforts and stable market conditions. The company’s disciplined pricing actions and operational improvements contributed to better-than-expected earnings.
Looking forward, Envista’s updated guidance is underpinned by expectations for continued stability in the dental market, further Spark gross margin improvements, and successful tariff mitigation efforts. Management raised its full-year adjusted EPS outlook and expects Spark to turn profitable in the second half. CFO Eric Hammes noted that “our playbook remains unchanged,” emphasizing ongoing supply chain actions, moderate price increases, and productivity gains. The company is also monitoring tariff impacts and currency volatility, with recent hedging activity aimed at reducing future FX transaction losses.
Management attributed the positive quarter to strategic investments in sales, marketing, and R&D, successful new product introductions, and operational discipline that offset external pressures such as tariffs and currency fluctuations.
Envista’s outlook is shaped by stable dental market trends, Spark profitability milestones, and ongoing operational improvements that aim to offset macro and regulatory headwinds.
Looking ahead, our analyst team will focus on (1) Spark Clear Aligners’ path to profitability and whether unit cost reductions continue, (2) the impact of further tariff mitigation and FX hedging on margins, and (3) signs of demand stabilization or recovery in China—especially as VBP policies evolve. We will also watch the adoption trajectory of new product launches and whether operational efficiencies hold as sales and R&D investment increases.
Envista currently trades at $20.90, up from $18.92 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Feb-18 | |
| Feb-15 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 | |
| Feb-11 | |
| Feb-11 | |
| Feb-10 | |
| Feb-10 | |
| Feb-10 | |
| Feb-10 | |
| Feb-09 | |
| Feb-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite